Call Options Transactions Made in Q4 2022 in Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO) during Q4 2022. The information is specifically focused on institutions that hold call options of HALOZYME THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
CALL |
127KNew |
$5.1M - $7.57M
|
127K
$6M
|
|
|
Feb 14, 2023
Q4 2022
|
Nomura Holdings Inc
Tokyo, M0 |
BUY
|
CALL |
82.5KNew |
$3.3M - $4.9M
|
82.5K
$3.89M
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
23.3K+ 14.68% |
$933K - $1.38M
|
182K
$8.58M
|
|
|
Feb 10, 2023
Q4 2022
|
Peak6 Investments LLC
Chicago, IL |
BUY
|
CALL |
23.1KNew |
$925K - $1.37M
|
23.1K
$1.09M
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
9.2K+ 28.13% |
$369K - $547K
|
41.9K
$1.98M
|
|
|
Feb 14, 2023
Q4 2022
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
1K+ 90.91% |
$40.1K - $59.4K
|
2.1K
$99K
|
|
|
Feb 14, 2023
Q4 2022
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-200- 50.0% |
$8.01K - $11.9K
|
200
$9.43K
|